Literature DB >> 18025426

Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease.

William D T Kent1, Stephen F Hall, Phillip A Isotalo, Robyn L Houlden, Ralph L George, Patti A Groome.   

Abstract

BACKGROUND: Recent reports from North America and Europe have documented an annual increase in the incidence of differentiated thyroid carcinoma. We sought to investigate the relation between rates of detection, tumour size, age and sex.
METHODS: Using the Ontario Cancer Registry, we identified 7422 cases of differentiated thyroid carcinoma diagnosed from Jan. 1, 1990, to Dec. 31, 2001. We obtained pathology reports for a random 10% of the 7422 patients for each year of the study period. The sample represented all Cancer Care Ontario regions. We compared the size of the patients' tumours by year, sex and age.
RESULTS: As expected, the incidence of differentiated thyroid carcinoma increased over the 12-year period. A significantly higher number of small (< or = 2 cm), nonpalpable tumours were resected in 2001 than in 1990 (p = 0.001). The incidence of tumours 2-4 cm in diameter remained stable. When we examined differences in tumour detection rates by age and sex, we observed a disproportionate increase in the number of small tumours detected among women and among patients older than 45 years.
INTERPRETATION: Our findings suggest that more frequent use of medical imaging has led to an increased detection rate of small, subclinical tumours, which in turn accounts for the higher incidence of differentiated thyroid carcinoma. This suggests that we need to re-evaluate our understanding of the trends in thyroid cancer incidence.

Entities:  

Mesh:

Year:  2007        PMID: 18025426      PMCID: PMC2072986          DOI: 10.1503/cmaj.061730

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  32 in total

1.  Utilization of outpatient diagnostic imaging. Does the physician's gender play a role?

Authors:  M P Rosen; R B Davis; L G Lesky
Journal:  J Gen Intern Med       Date:  1997-07       Impact factor: 5.128

2.  Diet and the risk of papillary and follicular thyroid carcinoma: a population-based case-control study in Sweden and Norway.

Authors:  M R Galanti; L Hansson; R Bergström; A Wolk; A Hjartåker; E Lund; L Grimelius; A Ekbom
Journal:  Cancer Causes Control       Date:  1997-03       Impact factor: 2.506

3.  Thyroid cancer: is the incidence still increasing?

Authors:  Nicole C Hodgson; Jaclyn Button; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2004-12       Impact factor: 5.344

4.  Thyroid incidentalomas: a new epidemic.

Authors:  Jamie C Mitchell; Sareh Parangi
Journal:  Curr Surg       Date:  2004 Nov-Dec

5.  Increasing incidence and changing presentation of thyroid cancer over a 30-year period.

Authors:  T J Fahey; T S Reeve; L Delbridge
Journal:  Br J Surg       Date:  1995-04       Impact factor: 6.939

Review 6.  An overview of the management of papillary and follicular thyroid carcinoma.

Authors:  E L Mazzaferri
Journal:  Thyroid       Date:  1999-05       Impact factor: 6.568

7.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].

Authors:  S A Hundahl; I D Fleming; A M Fremgen; H R Menck
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

8.  Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: evidence for the prolonged effects of radiation on the thyroid.

Authors:  A B Schneider; E Ron; J Lubin; M Stovall; T C Gierlowski
Journal:  J Clin Endocrinol Metab       Date:  1993-08       Impact factor: 5.958

9.  Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases.

Authors:  Y Yamamoto; T Maeda; K Izumi; H Otsuka
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

Review 10.  Radiation exposure and other factors that predispose to human thyroid neoplasia.

Authors:  D L Fraker
Journal:  Surg Clin North Am       Date:  1995-06       Impact factor: 2.741

View more
  96 in total

1.  Thyroid cancer presentation and treatment in the United States.

Authors:  Lindsey Enewold; Linda C Harlan; Jennifer L Stevens; Elad Sharon
Journal:  Ann Surg Oncol       Date:  2014-11-01       Impact factor: 5.344

2.  Nitrate intake and the risk of thyroid cancer and thyroid disease.

Authors:  Mary H Ward; Briseis A Kilfoy; Peter J Weyer; Kristin E Anderson; Aaron R Folsom; James R Cerhan
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

3.  Explaining the increasing incidence of differentiated thyroid cancer.

Authors:  Jacques How; Roger Tabah
Journal:  CMAJ       Date:  2007-11-20       Impact factor: 8.262

4.  Cancer in Canada in 2008.

Authors:  Loraine D Marrett; Prithwish De; Parisa Airia; Dagny Dryer
Journal:  CMAJ       Date:  2008-11-18       Impact factor: 8.262

Review 5.  Managing newly diagnosed thyroid cancer.

Authors:  Anna M Sawka; James D Brierley; Shereen Ezzat; David P Goldstein
Journal:  CMAJ       Date:  2013-10-07       Impact factor: 8.262

6.  Current concepts and future directions in differentiated thyroid cancer.

Authors:  Donald S A McLeod
Journal:  Clin Biochem Rev       Date:  2010-02

7.  Thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.

Authors:  Lindsey R Enewold; Jing Zhou; Susan S Devesa; Amy Berrington de Gonzalez; William F Anderson; Shelia H Zahm; Alexander Stojadinovic; George E Peoples; Aizenhawar J Marrogi; John F Potter; Katherine A McGlynn; Kangmin Zhu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-09-13       Impact factor: 4.254

8.  Rising incidence of thyroid cancer in Serbia.

Authors:  N Slijepcevic; V Zivaljevic; I Paunovic; A Diklic; Perisic Zivkovic; D Miljus; A Grgurevic; S Sipetic
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

9.  Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype.

Authors:  J H Shulin; J Aizhen; S M Kuo; W B Tan; K Y Ngiam; R Parameswaran
Journal:  Ann R Coll Surg Engl       Date:  2018-03-15       Impact factor: 1.891

10.  NDRG1 protein overexpression in malignant thyroid neoplasms.

Authors:  Renê Gerhard; Suely Nonogaki; José Humberto Tavares Guerreiro Fregnani; Fernando Augusto Soares; Maria Aparecida Nagai
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.